Profile data is unavailable for this security.
About the company
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
- Revenue in USD (TTM)416.63m
- Net income in USD149.20m
- Incorporated2008
- Employees581.00
- LocationInmode LtdTavor Building, Sha'ar Yokneam, Pob 533YOKNEAM 2069200IsraelISR
- Phone+972 49097470
- Websitehttps://inmodemd.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Embecta Corp | 1.12bn | 69.70m | 779.55m | 2.20k | 11.20 | -- | 7.20 | 0.6967 | 1.21 | 1.21 | 19.36 | -13.24 | 0.8882 | 2.11 | 11.60 | 508,590.90 | 5.53 | -- | 7.91 | -- | 66.42 | -- | 6.23 | -- | 1.61 | 2.06 | 1.88 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
Castle Biosciences Inc | 287.59m | -3.10m | 814.07m | 610.00 | -- | 1.92 | 81.51 | 2.83 | -0.1346 | -0.1346 | 10.45 | 15.30 | 0.6302 | 7.38 | 7.44 | 471,457.40 | -0.6791 | -9.43 | -0.7383 | -10.17 | 81.86 | 80.58 | -1.08 | -28.46 | 7.92 | -- | 0.0238 | -- | 60.38 | 57.35 | 14.41 | -- | 117.94 | -- |
Bioventus Inc | 536.89m | -41.96m | 951.44m | 1.03k | -- | 6.30 | -- | 1.77 | -0.6595 | -0.6595 | 8.48 | 1.86 | 0.6591 | 1.95 | 4.18 | 553,495.90 | -6.70 | -5.52 | -9.65 | -7.27 | 66.53 | 68.25 | -10.16 | -10.94 | 0.956 | 1.08 | 0.6697 | -- | 0.0445 | 9.93 | 6.91 | -- | 23.51 | -- |
Pulse Biosciences Inc | 0.00 | -44.02m | 979.42m | 56.00 | -- | 32.72 | -- | -- | -0.7916 | -0.7916 | 0.00 | 0.4883 | 0.00 | -- | -- | 0.00 | -76.43 | -93.21 | -84.97 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
Avanos Medical Inc | 682.40m | 7.00m | 1.07bn | 3.77k | 151.46 | 0.872 | 20.43 | 1.56 | 0.1532 | 0.1671 | 14.71 | 26.62 | 0.4105 | 1.93 | 5.20 | 180,960.00 | 0.4211 | -0.6527 | 0.4737 | -0.7338 | 55.82 | 54.45 | 1.03 | -1.60 | 1.49 | 7.06 | 0.1253 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
Artivion Inc | 376.97m | -8.32m | 1.11bn | 1.50k | -- | 3.74 | 73.79 | 2.94 | -0.2076 | -0.2076 | 9.11 | 7.06 | 0.481 | 1.67 | 5.44 | 251,316.00 | -1.07 | -2.20 | -1.15 | -2.36 | 64.63 | 65.51 | -2.22 | -5.34 | 4.04 | 1.07 | 0.5177 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
Owens & Minor, Inc. | 10.53bn | -42.44m | 1.13bn | 13.70k | -- | 1.31 | 4.72 | 0.1075 | -0.5532 | -0.5532 | 137.98 | 11.17 | 1.99 | 6.95 | 15.78 | 768,728.30 | -0.8014 | 1.32 | -1.25 | 2.07 | 20.78 | 16.48 | -0.403 | 0.5614 | 0.5141 | 2.11 | 0.7076 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
BioLife Solutions Inc | 121.17m | -53.87m | 1.13bn | 409.00 | -- | 3.52 | -- | 9.34 | -1.21 | -1.64 | 2.69 | 6.97 | 0.2999 | 1.99 | 5.39 | 296,254.30 | -13.33 | -13.76 | -14.60 | -15.04 | 41.27 | 36.76 | -44.46 | -42.99 | 1.81 | -5.98 | 0.0651 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
Figs Inc | 550.80m | 18.68m | 1.14bn | 354.00 | 65.12 | 2.85 | 51.32 | 2.08 | 0.1029 | 0.1029 | 3.04 | 2.35 | 1.18 | 1.23 | 58.02 | 1,555,932.00 | 3.99 | -- | 4.65 | -- | 68.02 | -- | 3.39 | -- | 3.89 | -- | 0.00 | -- | 7.87 | -- | 6.85 | -- | -- | -- |
Inmode Ltd | 416.63m | 149.20m | 1.20bn | 581.00 | 9.11 | 1.74 | 8.03 | 2.89 | 1.73 | 1.73 | 4.84 | 9.09 | 0.5228 | 1.62 | 11.78 | 717,084.30 | 18.72 | 31.32 | 20.79 | 35.64 | 82.27 | 84.46 | 35.81 | 39.65 | 8.09 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
Establishment Labs Holdings Inc | 151.35m | -83.20m | 1.26bn | 857.00 | -- | 28.09 | -- | 8.35 | -3.11 | -3.11 | 5.62 | 1.61 | 0.5307 | 0.8525 | 2.72 | 166,685.00 | -29.17 | -33.22 | -34.29 | -41.12 | 66.04 | 64.73 | -54.97 | -43.19 | 2.91 | -20.68 | 0.8114 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
Integra Lifesciences Holdings Corp | 1.57bn | 23.65m | 1.32bn | 3.95k | 57.41 | 0.8597 | 8.65 | 0.8419 | 0.2961 | 0.2961 | 20.02 | 19.77 | 0.399 | 1.55 | 5.81 | 396,986.10 | 0.6023 | 3.33 | 0.6618 | 3.68 | 61.54 | 63.67 | 1.51 | 7.99 | 2.10 | 5.88 | 0.5433 | 0.00 | -1.03 | 0.9219 | -62.48 | 2.19 | -2.97 | -- |
AtriCure Inc | 429.95m | -40.12m | 1.35bn | 1.20k | -- | 2.91 | -- | 3.13 | -0.8606 | -0.8606 | 9.22 | 9.49 | 0.7217 | 1.68 | 8.27 | 358,294.20 | -6.73 | -3.72 | -7.58 | -4.10 | 74.84 | 74.36 | -9.33 | -7.64 | 2.93 | -11.79 | 0.12 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
Adapthealth Corp | 3.26bn | -692.75m | 1.40bn | 10.70k | -- | 0.9372 | -- | 0.4305 | -5.17 | -5.17 | 24.29 | 11.14 | 0.6714 | 22.22 | 8.12 | 304,741.80 | -14.15 | -4.34 | -15.89 | -4.89 | 18.63 | 18.28 | -21.07 | -6.47 | 0.9438 | 2.17 | 0.5866 | -- | 7.73 | -- | -1,169.99 | -- | -- | -- |
Novocure Ltd | 549.96m | -168.70m | 1.59bn | 1.45k | -- | 4.40 | -- | 2.90 | -1.58 | -1.58 | 5.13 | 3.35 | 0.4639 | 3.62 | 8.11 | 378,502.40 | -14.23 | -7.74 | -16.44 | -8.95 | 75.83 | 77.22 | -30.67 | -14.69 | 6.22 | -- | 0.6437 | -- | -5.30 | 15.47 | -123.75 | -- | 32.19 | -- |
Holder | Shares | % Held |
---|---|---|
BlackRock Fund Advisorsas of 31 Mar 2024 | 5.34m | 6.31% |
Fidelity Investments Canada ULCas of 31 Mar 2024 | 3.40m | 4.02% |
Renaissance Technologies LLCas of 30 Jun 2024 | 2.07m | 2.44% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.89m | 2.23% |
LSV Asset Managementas of 30 Jun 2024 | 1.86m | 2.20% |
Boston Trust Walden, Inc.as of 30 Jun 2024 | 1.44m | 1.71% |
Meitav Mutual Funds Ltd.as of 30 Jun 2024 | 1.43m | 1.69% |
DDD Partners LLCas of 30 Jun 2024 | 1.27m | 1.50% |
DOMA Perpetual Capital Management LLCas of 31 Mar 2024 | 1.18m | 1.40% |
Menora Mivtachim Insurance Ltd.as of 31 Mar 2024 | 1.17m | 1.39% |